Bausch Lomb Corp (BLCO)

Mar 03, 2025

Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update - GlobeNewswire Inc.

Mar 03, 2025

Feb 24, 2025

HC Wainwright Has Negative View of Bausch + Lomb Q1 Earnings - Defense World

Feb 24, 2025

Feb 24, 2025

Bausch + Lomb Co. (NYSE:BLCO) Receives Average Rating of “Hold” from Analysts - Defense World

Feb 24, 2025

Feb 22, 2025

Bank of America Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $17.00 - Defense World

Feb 22, 2025

Feb 20, 2025

Bausch + Lomb Corporation (NYSE:BLCO) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

Feb 19, 2025

Bausch & Lomb Begins to Reap Fruits of Innovation; Broad-Based Growth Fuels Our Long-Term Outlook - Morningstar

Feb 19, 2025

Feb 19, 2025

Bausch + Lomb Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance - BioSpace

Feb 19, 2025

Feb 19, 2025

Bausch + Lomb Corp. Announces FY25 Revenue Within View - Nasdaq

Feb 19, 2025

Feb 19, 2025

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results - TradingView

Feb 19, 2025

Feb 19, 2025

Bausch + Lomb Posts Q4 Revenue of US$1.28 Billion -February 19, 2025 at 06:59 am EST - Marketscreener.com

Feb 19, 2025

Feb 18, 2025

Short Interest in Bausch + Lomb Co. (NYSE:BLCO) Increases By 37.3% - MarketBeat

Feb 18, 2025

Feb 18, 2025

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect - The Globe and Mail

Feb 18, 2025

Feb 06, 2025

Bausch + Lomb Sinks After Disclosing It Won’t Go Private Now - Bloomberg

Feb 06, 2025

Feb 06, 2025

Contact lens maker Bausch + Lomb rules out going private at this time - Reuters

Feb 06, 2025

Feb 06, 2025

Bausch + Lomb sinks after disclosing it won’t go private now - The Malaysian Reserve

Feb 06, 2025

Feb 06, 2025

Contact lens maker Bausch + Lomb rules out take-private deal - Yahoo Canada Finance

Feb 06, 2025

Feb 06, 2025

Bausch + Lomb Provides Update on Potential Sale - Business Wire

Feb 06, 2025

Feb 02, 2025

Brokerages Set Bausch + Lomb Co. (NYSE:BLCO) Target Price at $20.25 - MarketBeat

Feb 02, 2025

Jan 31, 2025

Stifel Nicolaus Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock Price - Defense World

Jan 31, 2025

Jan 30, 2025

Bausch Health Q4 Results to Focus on 2025 Outlook, Potential Full Separation of Bausch + Lomb, RBC Says - Marketscreener.com

Jan 30, 2025

Jan 30, 2025

Bausch + Lomb Co. (NYSE:BLCO) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Jan 30, 2025

Jan 22, 2025

Bausch Lomb Corporation (BLCO-T) QuotePress Release - The Globe and Mail

Jan 22, 2025

Jan 22, 2025

Bausch + Lomb Corporation - Baystreet.ca

Jan 22, 2025

Jan 22, 2025

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19 - Business Wire

Jan 22, 2025

Jan 21, 2025

This Bausch + Lomb Insider Increased Their Holding In The Last Year - Yahoo Finance

Jan 21, 2025

Jan 20, 2025

Ellsworth Advisors LLC Invests $665,000 in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat

Jan 20, 2025

Jan 18, 2025

Wells Fargo & Company Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $24.00 - Defense World

Jan 18, 2025

Jan 13, 2025

Bausch + Lomb bolsters pipeline with acquisition of Whitecap Biosciences - ROI-NJ.com

Jan 13, 2025

Jan 13, 2025

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences - BioSpace

Jan 13, 2025

Jan 13, 2025

Bausch + Lomb Launches enVista Aspire IOLs in Europe - TipRanks

Jan 13, 2025

Jan 13, 2025

Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union - Business Wire

Jan 13, 2025

Jan 13, 2025

B%2BL+affiliate+acquires+California-based+pharmaceutical+company+%C2%A0 - Rochester Business Journal

Jan 13, 2025

Jan 12, 2025

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20? - Yahoo Finance

Jan 12, 2025

Jan 10, 2025

Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine - Yahoo Finance

Jan 10, 2025

Jan 10, 2025

City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy - Yahoo Finance

Jan 10, 2025

Jan 08, 2025

Implantable Drug Delivery Devices Business Research Report 2023-2024 & 2030 - GlobeNewswire Inc.

Jan 08, 2025

Jan 07, 2025

S&P 500 Futures Rise in Premarket Trading; Aurora Innovation, Bausch + Lomb Lead - Barron's

Jan 07, 2025

Jan 07, 2025

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge - Business Wire

Jan 07, 2025

Jan 05, 2025

Bausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Jan 05, 2025

Jan 04, 2025

Bausch + Lomb Co. (NYSE:BLCO) Shares Acquired by State Street Corp - Defense World

Jan 04, 2025

Jan 02, 2025

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Jan 02, 2025

Jan 01, 2025

Warburg Pincus to buy Bausch & Lomb for $3.67 bln - Reuters

Jan 01, 2025

Dec 23, 2024

Aesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer - Yahoo Finance

Dec 23, 2024

Dec 20, 2024

Bausch + Lomb down after report that Blackstone could back away from takeover bid - MSN

Dec 20, 2024

Dec 19, 2024

BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN

Dec 19, 2024

Dec 16, 2024

Y Intercept Hong Kong Ltd Makes New Investment in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat

Dec 16, 2024